PharmaShots | Incisive News in 3 Shots

Subscribe Now

Crohn disease

PharmaShots Interview: Janssen's Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) as a First-Line Treatment Option in Crohn's Disease

PharmaShots Interview: Janssen's Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) a...

August 17, 2021

NeuClone Reports Positive Results of NeuLara (biosimilar- ustekinumab) in P-l Study for Autoimmune Diseases

NeuClone Reports Positive Results of NeuLara (biosimilar- ustekinumab) in P-l Study for Autoimmune Diseases

October 21, 2020

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

October 13, 2020

Boehringer Ingelheim Report Results of BI 695501 in P-III Trial for Patients with Crohn's Disease

Boehringer Ingelheim Report Results of BI 695501 in P-III Trial for Patients with Crohn's Disease

December 17, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us